Palaiseau, Saclay Campus, France – HORIBA and GreenTropism have signed, 4th January 2021, a collaboration agreement. The two companies will combine their technologies for the development and commercialization of smart solutions combining HORIBA’s spectroscopic and hyperspectral imaging and GreenTropism’s data processing methods enhanced and automated by Artificial Intelligence. This collaboration will allow their respective and common […]

Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the new investigator-initiated study, called the Ge-Med […]

Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique genomic Knowledge Base and accelerate access New partnerships to deliver improved AI services and databases in oncology, secondary analysis and combined NGS panels and […]

– Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services – SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics […]

Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins in South Korea The contract provides up-front and milestone payments of $5 million USD and royalty payments thereafter on Amicogen’s net sales Bio-Works existing sales in South Korea are less than 1 million SEK per year, which […]

New testing reports will establish more appropriate markers for quality and for predicting effects through chemical composition SANTA CRUZ, Calif. — SC Laboratories, Inc., (SC Labs) has announced that it has licensed Napro Research LLC‘s proprietary data visualization tool PhytoFactsⓇ. Clients testing cannabis through the lab will now have access to this game-changing reporting format and algorithm that […]

Vancouver, British Columbia –  BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. has entered into a collaborative research and development agreement with Phytronix Technologies Inc. (“Phytronix”) to advance the development of BioMark’s early lung cancer screening applications using Phytronix-proprietary Laser Diode […]

ZeClinics is applying CRISPR technology to create gene edited zebrafish disease models Dublin, Ireland & Barcelona, Spain: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and ZeClinics, a contract research organization using zebrafish to carry out services focused on analyzing the safety, efficacy […]

Cytiva and Brooks Life Sciences are working together to enhance automation in the cryogenic cold chain Cytiva, a global life sciences leader, and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to seamlessly integrate Brooks Life Sciences BioStore III automated storage platform, which is purpose built […]

Partnership expands access to company’s leading biomarker technology and Simoa Accelerator Lab services into China and Asia Pacific (APAC) BILLERICA, Mass. — Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced it has entered into an agreement to open a joint Simoa laboratory with WuXi AppTec to improve access to Quanterix’ industry leading biomarker testing […]